About
PharmNovo AB is a clinical-stage pharmaceutical company developing a potential first-in-class treatment for neuropathic pain. The company’s candidate also has reported potential in adjacent indications such as migraine and chronic cough.
Explore PharmNovo AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.